BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 12446613)

  • 1. A role for Grb2-associated binder-1 in growth hormone signaling.
    Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
    Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
    Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling.
    Kim SO; Jiang J; Yi W; Feng GS; Frank SJ
    J Biol Chem; 1998 Jan; 273(4):2344-54. PubMed ID: 9442080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y; Kim SO; Jiang J; Frank SJ
    J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2.
    VanderKuur J; Allevato G; Billestrup N; Norstedt G; Carter-Su C
    J Biol Chem; 1995 Mar; 270(13):7587-93. PubMed ID: 7535773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
    Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
    Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules.
    Rocchi S; Tartare-Deckert S; Murdaca J; Holgado-Madruga M; Wong AJ; Van Obberghen E
    Mol Endocrinol; 1998 Jul; 12(7):914-23. PubMed ID: 9658397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1.
    Wang X; Yang N; Deng L; Li X; Jiang J; Gan Y; Frank SJ
    Mol Endocrinol; 2009 Apr; 23(4):486-96. PubMed ID: 19164446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and biological responses induced by coupling of Gab1 to phosphatidylinositol 3-kinase in RET-expressing cells.
    Maeda K; Murakami H; Yoshida R; Ichihara M; Abe A; Hirai M; Murohara T; Takahashi M
    Biochem Biophys Res Commun; 2004 Oct; 323(1):345-54. PubMed ID: 15351743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
    Goh EL; Zhu T; Leong WY; Lobie PE
    Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Grb2-associated binder 1/SHP-2 interaction in cell growth and transformation.
    Holgado-Madruga M; Wong AJ
    Cancer Res; 2004 Mar; 64(6):2007-15. PubMed ID: 15026337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.
    Sotiropoulos A; Moutoussamy S; Renaudie F; Clauss M; Kayser C; Gouilleux F; Kelly PA; Finidori J
    Mol Endocrinol; 1996 Aug; 10(8):998-1009. PubMed ID: 8843416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes.
    Eriksson H; Ridderstråle M; Tornqvist H
    Endocrinology; 1995 Nov; 136(11):5093-101. PubMed ID: 7588246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the mitogen-activated protein kinase signaling pathway by SHP2.
    Cunnick JM; Meng S; Ren Y; Desponts C; Wang HG; Djeu JY; Wu J
    J Biol Chem; 2002 Mar; 277(11):9498-504. PubMed ID: 11779868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements.
    Huang Y; Kim SO; Yang N; Jiang J; Frank SJ
    Mol Endocrinol; 2004 Jun; 18(6):1471-85. PubMed ID: 15044591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.